Definium Therapeutics, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2023
Total Assets: $124.5M
Liabilities Breakdown FY2023
Total Liabilities: $46.4M
Asset Breakdown
Total Assets: $124.5M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $99.7M | 80.1% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $0 | 0.0% |
| Goodwill | $19.9M | 16.0% |
| Intangible Assets | $527.0K | 0.4% |
| Other Assets | $4.4M | 3.5% |
Liabilities Breakdown
Total Liabilities: $46.4M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $4.1M | 8.9% |
| Long-Term Debt | $14.1M | 30.4% |
| Other Liabilities | $28.1M | 60.6% |